CHEK2/T470C is associated with reduced DNA repair ability and increased cancer susceptibility, such as breast cancer, colorectal cancer and prostate cancer (Han et al. 2013; Kilpivaara et al. 2006; Dong et al. 2003). Here, CHEK2 is linked to prostate carcinoma.